Publications

Navigante AH, Castro MA, Cerchietti LC.  2010.  Morphine versus midazolam as upfront therapy to control dyspnea perception in cancer patients while its underlying cause is sought or treated.. J Pain Symptom Manage. 39(5):820-30.

Cerchietti LCA, Navigante AH, Castro MA.  2007.  Effects of eicosapentaenoic and docosahexaenoic n-3 fatty acids from fish oil and preferential Cox-2 inhibition on systemic syndromes in patients with advanced lung cancer.. Nutr Cancer. 59(1):14-20.

Cerchietti LCA, Navigante AH, Lutteral MA, Castro MA, Kirchuk R, Bonomi M, Cabalar MEsther, Roth B, Negretti G, Sheinker B et al..  2006.  Double-blinded, placebo-controlled trial on intravenous L-alanyl-L-glutamine in the incidence of oral mucositis following chemoradiotherapy in patients with head-and-neck cancer.. Int J Radiat Oncol Biol Phys. 65(5):1330-7.

Navigante AH, Cerchietti LCA, Castro MA, Lutteral MA, Cabalar ME.  2006.  Midazolam as adjunct therapy to morphine in the alleviation of severe dyspnea perception in patients with advanced cancer.. J Pain Symptom Manage. 31(1):38-47.

Cerchietti LCA, Bonomi MR, Navigante AH, Castro MA, Cabalar ME, Roth BMC.  2005.  Phase I/II study of selective cyclooxygenase-2 inhibitor celecoxib as a radiation sensitizer in patients with unresectable brain metastases.. J Neurooncol. 71(1):73-81.

Navigante AH, Cerchietti LCA, Costantini P, Salgado H, Castro MA, Lutteral MA, Cabalar ME.  2002.  Conventional chest radiography in the initial assessment of adult cancer patients with fever and neutropenia.. Cancer Control. 9(4):346-51.